恶性胸膜间皮瘤的免疫治疗耐药与策略
Immunotherapy resistance and strategies in malignant pleural mesothelioma.
65.3分
★★★☆☆
站内排序·非疗效
MODALITY HUB
FOR TREATMENT
现在就能报名的(招募中)排在最前,共 1 项。同一状态内中国中心优先。信息来自 ClinicalTrials.gov 与 CDE 公开登记。能否入组、费用与可及性,以登记原文和主治医生判断为准。
FOR RESEARCH
Immunotherapy resistance and strategies in malignant pleural mesothelioma.
Non-pathogenic E. coli displaying decoy-resistant IL18 mutein boosts anti-tumor and CAR NK cell responses.
Activation of Tumor-Cell STING Primes NK-Cell Therapy.
Natural Killer Cells in Cancers of Respiratory System and Their Applications in Therapeutic Approaches.
呼吸系统癌症在全球范围内构成重大健康挑战,而尽管 NK 细胞在肿瘤监视中发挥关键作用,肿瘤仍常通过多种机制逃逸 NK 细胞应答。
Nonpathogenic E. coli engineered to surface display cytokines as a new platform for immunotherapy.
MEMBER ACCOUNT
登录成功会直接打开下一页。